Archives

by in
Entry Author Date Location
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
What’s in a Name? A Lot, When It Comes to ‘Precision Medicine’ 02/04/13 National
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Can NYC Create an Infrastructure for Medical Device Startups? 01/17/13 New York
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Can New York Take on Boston, California as a Biotech Hub? 10/11/12 New York
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center 11/03/11 New York
New York Genome Center to Open in February, Supported by $125M in Public and Private Funding 11/02/11 New York
Exelixis To Push Ahead on Prostate Cancer Trial Without FDA Agreement: Shares Plunge 10/31/11 San Francisco
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech 10/27/11 New York
The Genetics Institute Impact: Join Mark Ptashne, Tom Maniatis & Gabe Schmergel on Dec. 14 10/11/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
NYC Scientists Score $250,000 Awards in Annual BioAccelerate Competition 05/25/11 New York
Polaris Expands Ludwig Collaboration 05/19/11 San Diego
Biotech’s Missed Opportunity: Small-Town and Rural America 04/18/11 National
Public Policy Institute on How to Boost Biotech in New York: More Jobs, Better Teamwork, Fewer Taxes 04/12/11 New York
Columbia University’s Tech Transfer Guru, Orin Herskowitz, on Turning IT, Biotech, and Cleantech Ideas Into Businesses 04/04/11 New York
Calypso Axes 15 Percent of Staff, Pares Down U.S. Sales Force for Prostate Cancer Technology 08/13/10 Seattle
RainDance Technologies, Delving Deep into DNA, Gets Wall Street Connections with Latest CEO 07/27/10 Boston
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer 04/29/10 Seattle
ISB Nabs $8M for Cancer Genome 11/10/09 Seattle
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings 06/01/09 Boston
Aveo Kidney Cancer Drug, Challenging Pfizer and Bayer, Passes Important Test 05/29/09 Boston
Page 2 of 3 « previous page · next page »